Study Programmes 2015-2016
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Bernard Pirotte

Learning units :  
 
CHIM0218-1 Elements of medicinal chemistry Holder
CHIM0332-2 Pharmaceutical Chemistry (Part I) Holder
CHIM0333-2 Pharmaceutical Chemistry (Part II) Holder
CHIM0684-1 Pharmaceutical Chemistry Personal Reasearch Work Holder
MSTG0352-2 Research internship abroad Holder
MSTG0353-2 Developpment cooperation internship abroad Holder
MSTG0354-1 Research internship in francophone Belgium Holder
MSTG0453-2 Training : medicinal chemistry Holder
MSTG2048-2 Placement : industrial practices Holder
MTFE0351-1 Officinal Internship and Thesis  Holder
- Knowledges integration
- Record of learning and participation to clinical research project
- Officinal internship and Thesis
PHAR0005-1 Introduction to specialized focus in conception and develoment of medicine - bioanalysis  Holder
- Visites industrielles
- Introduction à la biologie clinique
- Médicaments d'origine biosynthétique
- Stratégies de découverte des médicaments
- Chimie structurale des médicaments
- Management pharmaceutique
- Assurance de qualité
- Technologie pharmaceutique industrielle
- Analyses biopharmaceutiques
- Affaires règlementaires
- Etudes cliniques
- Méthodologie de rédaction
PHAR0006-1 Introduction to professional focus in officinal practice, advice and pharmaceutical follow-up Holder
- Gestion des médicaments anti-infectieux
- Complément de phytothérapie
- Dermopharmacie
- Gestion officinale
- Approche critique de l'homéopathie
- Mycologie
- Soins lourds à domicile
- Médicaments à usage vétérinaire
- Approche critique des compléments alimentaires
- Médicaments, grossesse et allaitement
- Médicaments chez la personne âgée
- Méthodologie de rédaction
PHAR0007-1 Personal research work  Holder
PHAR2019-1 Integrated Seminars I Holder
PHAR2020-1 Integrated practical work Holder
PHAR2024-1 Personal research work in industrial pharmaceutical practice Holder
PHAR2219-1 Integrated work 2 Holder
PHIN2004-1 Active substances Holder
- Substances emerging from pharmacochemical research, part a
- Substances emerging from pharmacochemical research, part b
- Substances emerging from biotechnology,
- Substances of natural origin, part a
- Substances of natural origin, part b
- Radiopharmaceuticals products,